CA$
0. 17
+0.01
+6.4516%
CA$
7.58M Market Cap
- P/E Ratio
- Div Yield
437,629 Volume
- Eps
CA$ 0.15
Previous Close Want to track MDMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pharmala Biotech Holdings Inc. (MDMA) Statistics
Valuation metrics
Market Cap 7.58M
Enterprise value 15.2M
Trailing P/E (ttm) -9.4
Forward P/E -
PEG ratio -0.31
Price/Sales (ttm) 12.06
Price/Book (mrq) 7.91
Enterprise Value/Revenue 11.99
Enterprise Value/EBITDA -10.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 70.17K
Average volume (90 days) 101.64K
Price summary
52-Week low 0.09
52-Week high 0.19
Beta -
50-Day moving average 0.15
200-Day moving average 0.13
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.27%
Operating margin -1.2%
Operational effectiveness
Return on assets -0.52%
Return on equity -0.72%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.17%
Book value per share (mrq) 0.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
